Literature DB >> 3103737

Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?

R Madhok, H A Capell, R Waring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3103737      PMCID： PMC1245526          DOI： 10.1136/bmj.294.6570.483

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  R H Waring; S C Mitchell; R R Shah; J R Idle; R L Smith
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

2.  Captopril: a new treatment for rheumatoid arthritis?

Authors:  M F Martin; K E Surrall; F McKenna; J S Dixon; H A Bird; V Wright
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

3.  D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.

Authors:  P Emery; G S Panayi; G Huston; K I Welsh; S C Mitchell; R R Shah; J R Idle; R L Smith; R H Waring
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

4.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245
  4 in total
  8 in total

1.  Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.

Authors:  P Emery; H Bradley; A Gough; V Arthur; R Jubb; R Waring
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Disease-modifying drugs for rheumatoid arthritis. Asset or liability?

Authors:  H A Bird
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

Review 4.  Management of adverse effects of disease-modifying antirheumatic drugs.

Authors:  M J Wijnands; P L van Riel
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

Review 5.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

6.  The natural course of gold nephropathy: long term study of 21 patients.

Authors:  C L Hall; N J Fothergill; M M Blackwell; P R Harrison; J C MacKenzie; A G MacIver
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

7.  Gold causes genetically determined autoimmune and immunostimulatory responses in mice.

Authors:  S Havarinasab; U Johansson; K M Pollard; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

8.  Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.

Authors:  C Astbury; A J Taggart; L Juby; L Zebouni; H A Bird
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.